SCHEMBL13701265

SCHEMBL13701265

CCCCCCCCCCCCCCCCCC(=O)N[C@H]1CCCC[C@H]1NC(=O)CCCCCCCCCCCCCCCCC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 6/20 0.69
CNR1 P21554 4/20 0.69
CNR2 P34972 4/20 0.69
GNAI3 P08754 1/20 0.57
GNAO1 P09471 1/20 0.57
GNAI1 P63096 1/20 0.57
CCR2 P41597 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.55
HSP90AA1 P07900 1/20 0.52
MEN1 O00255 1/20 0.52
FAAH O00519 1/20 0.52
MAPK1 P28482 1/20 0.52
KMT2A Q03164 1/20 0.52
HDAC3 O15379 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5152781 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL776430 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL19963567 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL12555492 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL19963564 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL13870526 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL13870525 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL247278 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL775515 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1
SCHEMBL13949790 1.00 TRPV1 (0.69) TRPV1CNR1CNR2GNAI3GNAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8851648-B2 Blends of semi-crystalline materials for inks for direct-to-paper printing XEROX CORPORATION (US) 2014-10-07 US disclosed
US-20140078227-A1 BLENDS OF SEMI-CRYSTALLINE MATERIALS FOR INKS FOR DIRECT-TO-PAPER PRINTING XEROX CORPORATION (US) 2014-03-20 US disclosed
US-20090223409-A1 COMPOUNDS SUITABLE FOR USE IN INKS AND INKS HAVING SUCH COMPOUNDS XEROX CORPORATION (US) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090223409-A1 COMPOUNDS SUITABLE FOR USE IN INKS AND INKS HAVING SUCH COMPOUNDS DOT1L, ACR, TYR TRPV1 3144/4885CNR1 3933/4885CNR2 3687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.